How to Get Alprostadil (Caverject/MUSE) in Idaho

At a glance
- Telehealth prescribing / legal in Idaho for alprostadil
- Compounding access / 503A pharmacies licensed to ship in Idaho
- Idaho Medicaid coverage / not covered for erectile dysfunction
- Dose forms available / intracavernosal injection (Caverject) and urethral suppository (MUSE)
- Standard dosing schedule / on-demand, not daily
- Typical starting dose (Caverject) / 2.5 mcg intracavernosal, titrated up to 40 mcg
- Typical starting dose (MUSE) / 125 to 250 mcg intraurethral
- First-response rate in trials / ~73% of men achieved erection in Linet et al. (NEJM 1996)
- Prescribing providers in Idaho / MD, DO, NP, PA all eligible under Idaho scope-of-practice rules
- Time from consultation to delivery / typically 3, 7 business days via telehealth plus mail-order pharmacy
What Is Alprostadil and Why Is It Used for Erectile Dysfunction?
Alprostadil is a synthetic form of prostaglandin E1 (PGE1) that relaxes smooth muscle in penile arterial walls and increases local blood flow, producing an erection independent of sexual arousal pathways. It is one of the few FDA-approved therapies for erectile dysfunction (ED) that works when oral phosphodiesterase-5 (PDE5) inhibitors such as sildenafil or tadalafil have failed or are contraindicated. The drug is available in two delivery formats: Caverject (Pfizer) as an intracavernosal injection and MUSE (Meda Pharmaceuticals) as a medicated urethral suppository.
In the landmark Linet et al. NEJM trial published in 1996 (N=296 men with chronic ED), intracavernosal alprostadil produced satisfactory erections in 94% of in-clinic titration attempts and achieved a clinically meaningful erection in approximately 73% of at-home injections across 8 weeks of follow-up, compared with 13% in the placebo group (P<0.001) [1]. MUSE carries a somewhat lower but still clinically significant response rate, with roughly 43% of men reporting successful intercourse in key trials, versus 7% on placebo [2].
FDA approval for Caverject dates to July 1995 and for MUSE to November 1996. Both carry the same active moiety; the difference is delivery route and bioavailability [3].
The 2018 American Urological Association (AUA) Erectile Dysfunction Guideline states: "Intracavernosal vasoactive drug therapy (alprostadil, papaverine/phentolamine, trimix) is recommended for men who do not respond to or cannot use oral pharmacotherapy." [4] This positions alprostadil squarely as a second-line treatment with a clear clinical pathway for prescription.
Is Alprostadil Legal to Prescribe via Telehealth in Idaho?
Telehealth prescribing of alprostadil is permitted in Idaho. The Idaho Telemedicine Act (Idaho Code § 54-5701 et seq.) allows licensed Idaho practitioners to establish a valid patient-provider relationship and issue prescriptions entirely through synchronous audio-video encounters, provided the clinical standard of care is met. Alprostadil is a Schedule-unscheduled prescription drug (it is not a controlled substance), which means it does not carry the additional telehealth restrictions that apply to Schedule II-IV medications under the DEA Ryan Haight Act.
A synchronous video visit lasting 20 to 30 minutes is typically sufficient for an initial evaluation. The provider reviews your symptom history, prior ED treatment attempts, cardiovascular status, and any relevant lab results. If the clinical picture supports alprostadil, the provider issues a prescription electronically to a pharmacy of your choice. In-office titration is standard clinical practice before self-injection begins, and some telehealth platforms coordinate with local urology offices in Idaho cities (Boise, Nampa, Idaho Falls, Meridian, Twin Falls) to complete the first supervised injection.
Idaho does not require an in-person physical examination solely for the purpose of prescribing a non-controlled medication, as long as the telehealth encounter meets the standard of care. Providers practicing across state lines must hold an active Idaho medical license or participate in the Interstate Medical Licensure Compact (IMLC), of which Idaho is a member state [5].
Who Can Prescribe Alprostadil in Idaho?
Several practitioner types hold prescriptive authority for alprostadil in Idaho under state scope-of-practice law.
Medical doctors (MD) and doctors of osteopathic medicine (DO) have full prescriptive authority. Urologists, primary care physicians, and men's health specialists all routinely prescribe alprostadil.
Nurse practitioners (NPs) in Idaho practice under full practice authority as of 2018 (Idaho Code § 54-1402). An NP does not require physician collaboration to prescribe alprostadil.
Physician assistants (PAs) in Idaho prescribe under a collaboration agreement with a supervising physician (Idaho Code § 54-1806). That agreement covers legend drugs including alprostadil.
The practical implication: telehealth platforms staffed by NPs can legally prescribe alprostadil to Idaho patients without routing every prescription through an MD. Patients should confirm the platform's provider credentials before booking, but NP-issued prescriptions are valid at any Idaho pharmacy or mail-order pharmacy.
What Labs Are Required Before Starting Alprostadil?
Alprostadil does not require the same hormonal panel as testosterone therapy, but a responsible prescriber will order baseline testing to rule out systemic causes of ED and to screen for contraindications. The following labs are standard at HealthRX and align with AUA guideline recommendations [4]:
Testosterone (total and free). Low testosterone is a reversible cause of ED that should be identified and addressed before or alongside alprostadil therapy. The AUA defines hypogonadism as total testosterone below 300 ng/dL on two morning measurements [6].
Fasting glucose or HbA1c. Diabetes is the most common vascular comorbidity driving ED. Roughly 50% of diabetic men develop ED within 10 years of diagnosis according to data from the Massachusetts Male Aging Study (N=1,709) [7]. Knowing baseline glycemic status affects both prognosis and dose selection.
Lipid panel. Dyslipidemia independently contributes to endothelial dysfunction; a lipid panel guides cardiovascular risk stratification.
Complete blood count (CBC) and basic metabolic panel (BMP). These detect anemia, renal impairment, and hepatic dysfunction that could complicate therapy.
PSA (prostate-specific antigen) in men over 40. Not a contraindication to alprostadil, but standard men's health screening.
Blood pressure measurement. Hypotension is a documented adverse effect of alprostadil, particularly MUSE. A baseline blood pressure reading is mandatory.
Most results are available within 2 to 4 business days through standard outpatient labs. Telehealth providers can order lab work to a local draw site such as LabCorp or Quest Diagnostics before or after your initial video visit. You do not need to complete labs before booking a consultation; many platforms accept lab results ordered concurrently.
How Do You Fill an Alprostadil Prescription in Idaho?
Idaho residents have three main pharmacy options.
Brand-Name Retail Pharmacies
Caverject Impulse (Pfizer) and MUSE (Meda) are stocked at major retail chains including Walgreens, CVS, Smith's Food and Drug (Kroger), and Fred Meyer locations across Boise, Nampa, Meridian, and Idaho Falls. A Caverject 10 mcg dual-chamber syringe (2-pack) retails for roughly $120 to $180 without insurance. MUSE 500 mcg suppositories (6-pack) retail for approximately $300 to $400.
Mail-Order Pharmacies
Mail-order pharmacies licensed to operate in Idaho can ship alprostadil directly to a patient's home in temperature-controlled packaging. Caverject requires refrigeration (2 to 8 degrees Celsius) after reconstitution but is stable at room temperature before mixing. Most mail-order shipments arrive within 3 to 5 business days of prescription transmission.
503A Compounding Pharmacies
Idaho law permits 503A compounding pharmacies to prepare patient-specific alprostadil formulations, including custom concentrations, combination formulations (such as trimix, which combines alprostadil with papaverine and phentolamine), and alternative delivery vehicles. A 503A pharmacy operates under a valid prescription and compounds for individual patients rather than in bulk [8].
Compounded alprostadil often costs significantly less than branded Caverject. A 10 mL multi-dose vial of compounded alprostadil 20 mcg/mL through a 503A pharmacy may run $60 to $120, compared with $180 or more for two branded Caverject 10 mcg syringes. Idaho Medicaid does not cover alprostadil for ED, so cost matters for most patients. Verify that any 503A pharmacy you use holds an active Idaho Board of Pharmacy registration or is registered to ship into Idaho as an out-of-state non-resident pharmacy.
Does Insurance or Idaho Medicaid Cover Alprostadil?
Idaho Medicaid does not cover alprostadil for erectile dysfunction. This mirrors the coverage stance of most state Medicaid programs, which classify ED treatments as elective rather than medically necessary.
Private insurance coverage varies widely. Some commercial plans cover Caverject under the medical benefit (when administered in-office) rather than the pharmacy benefit, and others exclude it entirely. Prior authorization (PA) is required by most insurers that do offer any coverage. The PA documentation typically includes:
- Documented failure of at least two oral PDE5 inhibitors (sildenafil and tadalafil are commonly specified) at adequate doses
- A physician or specialist attestation of medical necessity
- Diagnosis code N52.x (male erectile dysfunction)
- Relevant medical history such as post-prostatectomy status, diabetes, or cardiovascular disease
The AUA 2018 ED guideline notes that "failure of oral agents or the presence of contraindications to oral agents represents an appropriate pathway to second-line therapy" [4], language insurers recognize in PA appeals. If your initial PA is denied, a written appeal citing the NEJM Linet data [1] and the AUA guideline recommendation often succeeds.
Medicare Part D may cover MUSE or Caverject depending on the specific plan formulary. Patients on Medicare Advantage plans should check the Evidence of Coverage document or call their plan's pharmacy benefits line before filling.
Can You Transfer an Alprostadil Prescription to Idaho?
Transferring an existing alprostadil prescription from another state to Idaho is straightforward. Federal law (21 CFR 1306.25) governs controlled-substance transfers; alprostadil is not a controlled substance, so transfers are governed by state board of pharmacy rules. Idaho allows one-time prescription transfers between pharmacies for non-controlled drugs, and Idaho does not require a new in-state prescription to fill a valid out-of-state legend drug prescription at an Idaho-licensed pharmacy.
Practically speaking: bring the labeled bottle or the prescriber's contact information to any Idaho retail pharmacy, and the pharmacist can contact the originating pharmacy to transfer or re-verify the prescription. If you are moving to Idaho permanently, establishing care with an Idaho-licensed provider within 90 days is reasonable practice, particularly because alprostadil prescriptions typically carry refill limits and require periodic clinical review.
What Is the Standard Alprostadil Dosing Protocol?
Dosing is on-demand, not daily. You take alprostadil only when you intend to have sexual activity, generally 5 to 20 minutes before intercourse for the injection form and 5 to 10 minutes before for MUSE.
Caverject (intracavernosal injection):
- Starting dose: 2.5 mcg for neurogenic ED or 5 mcg for vasculogenic ED
- Titration: dose is increased by 2.5 to 5 mcg increments during in-office titration until an erection adequate for intercourse is achieved, lasting no longer than 60 minutes
- Maximum dose: 40 mcg per injection
- Frequency: no more than 3 injections per week, with at least 24 hours between doses
MUSE (medicated urethral suppository):
- Starting dose: 125 to 250 mcg
- Range: 125 to 1 to 000 mcg
- Frequency: no more than 2 doses per 24-hour period
The most common adverse effect with injection is mild penile pain at the injection site, reported in roughly 37% of patients in the Linet trial [1]. Prolonged erection (priapism, defined as erection lasting more than 4 hours) occurs in about 1% of users and is a medical emergency requiring same-day urological evaluation. MUSE can cause urethral burning (30 to 40% of users) and hypotension in the partner via vaginal absorption, which is why MUSE labeling recommends the use of a condom during intercourse with a pregnant partner [3].
What to Expect at Your HealthRX Telehealth Visit
A typical HealthRX intake visit for alprostadil takes 20 to 30 minutes via secure video. You will be asked about prior ED treatments (specifically PDE5 inhibitor trials, doses, and outcomes), cardiovascular history, prostate health, and any current medications. The prescribing provider will review any lab results you have available and may order additional testing.
If alprostadil is clinically appropriate, the provider will electronically transmit a prescription to your preferred pharmacy. Because self-injection technique is a patient safety requirement, HealthRX coordinates an in-office titration visit with a local Idaho urology practice or, for patients in rural Idaho counties, provides detailed instructional video content supplemented by a follow-up video call. The Idaho Telehealth Access Act specifically permits remote monitoring and follow-up for this purpose [5].
Most patients in Boise, Nampa, or Meridian can complete the full process, from initial consultation through first pharmacy fill, within 3 to 7 business days. Patients in more rural areas such as Pocatello, Twin Falls, or Coeur d'Alene may need 5 to 10 business days to account for shipping time.
How Alprostadil Compares to Other ED Treatments Available in Idaho
Alprostadil occupies a distinct clinical niche relative to PDE5 inhibitors and penile implants.
PDE5 inhibitors (sildenafil 25 to 100 mg, tadalafil 5 to 20 mg, vardenafil 5 to 20 mg) remain first-line for most men because they are oral, require no injection technique, and carry a favorable safety profile. Meta-analysis data covering over 16,000 patients show a mean IIEF-EF domain score improvement of roughly 6 to 7 points with PDE5 inhibitors versus placebo [9]. However, these drugs fail in 30 to 40% of men with severe vascular ED or post-prostatectomy nerve damage, and they are contraindicated with nitrates.
Alprostadil bypasses the nitric oxide signaling pathway entirely. It works in men with complete nerve damage and in those on nitrate therapy. That makes it the preferred pharmacological option for post-radical prostatectomy patients. A 2013 Cochrane review of penile rehabilitation after prostatectomy identified alprostadil as the agent with the most supporting evidence for preserving erectile tissue oxygenation [10].
Penile implants (inflatable or malleable prostheses) carry the highest long-term satisfaction rates, roughly 90 to 95% at 5 years, but require surgery, carry a 1 to 3% infection risk, and are irreversible. Alprostadil is appropriate for men who want effective pharmacotherapy before committing to surgery.
Trimix (alprostadil plus papaverine plus phentolamine), available through Idaho 503A compounding pharmacies, often produces stronger and more reliable erections than alprostadil alone at lower per-component doses, which reduces adverse effects. HealthRX providers can discuss whether trimix is appropriate for your individual case.
Practical Checklist: Getting Alprostadil in Idaho
Getting started is a five-step process.
- Book a telehealth visit with an Idaho-licensed provider or a provider holding an Idaho IMLC license.
- Complete baseline labs: total testosterone, HbA1c, fasting lipid panel, BMP, and blood pressure.
- Attend your video consultation. Bring documentation of prior PDE5 inhibitor trials if applicable.
- Receive your electronic prescription and choose a pharmacy: retail, mail-order, or Idaho-registered 503A compounder.
- Complete an in-office or supervised-remote injection titration before first home use.
If you carry private insurance, ask your provider to submit a PA request at the time of prescribing. Include diagnosis code N52.9 (male erectile dysfunction, unspecified), prior treatment failure documentation, and a copy of the AUA guideline recommendation.
Frequently asked questions
›How do I get an alprostadil (Caverject/MUSE) prescription in Idaho?
›What labs are needed before alprostadil (Caverject/MUSE) in Idaho?
›Are there telehealth providers in Idaho prescribing alprostadil (Caverject/MUSE)?
›How long until I receive alprostadil (Caverject/MUSE) in Idaho?
›Can I transfer an alprostadil (Caverject/MUSE) prescription to Idaho?
›Are 503A pharmacies in Idaho licensed to ship alprostadil?
›Who can prescribe alprostadil (Caverject/MUSE) in Idaho: MD vs. NP vs. PA?
›What documentation does prior authorization require in Idaho?
References
- Linet OI, Ogrinc FG. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. N Engl J Med. 1996;334(14):873-877. https://pubmed.ncbi.nlm.nih.gov/8638121/
- Padma-Nathan H, Hellstrom WJ, Kaiser FE, et al. Treatment of men with erectile dysfunction with transurethral alprostadil. N Engl J Med. 1997;336(1):1-7. https://pubmed.ncbi.nlm.nih.gov/8970933/
- U.S. Food and Drug Administration. Caverject (alprostadil) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020513s016lbl.pdf
- Burnett AL, Nehra A, Breau RH, et al. Erectile Dysfunction: AUA Guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29746670/
- Idaho Legislature. Idaho Telemedicine Act. Idaho Code § 54-5701 et seq. https://legislature.idaho.gov/statutesrules/idstat/title54/t54ch57/
- Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol. 2018;200(2):423-432. https://pubmed.ncbi.nlm.nih.gov/29601923/
- Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151(1):54-61. https://pubmed.ncbi.nlm.nih.gov/8254833/
- U.S. Food and Drug Administration. Compounding: 503A pharmacy framework. https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
- Tsertsvadze A, Fink HA, Yazdi F, et al. Oral phosphodiesterase-5 inhibitors and hormonal treatments for erectile dysfunction: a systematic review and meta-analysis. Ann Intern Med. 2009;151(9):650-661. https://pubmed.ncbi.nlm.nih.gov/19884626/
- Tal R, Alphs HH, Krebs P, Nelson CJ, Mulhall JP. Erectile function recovery rate after radical prostatectomy: a meta-analysis. J Sex Med. 2009;6(9):2538-2546. https://pubmed.ncbi.nlm.nih.gov/19490472/